Omnicyte
Branford · Founded 2012
About Omnicyte
Omnicyte is a biotechnology company that develops targeted treatments for cancer therapy. The company develops a proprietary Immuno-Oncology Platform Technology for recombinant targeted immunomodulators, ovarian cancer indication, small cell lung cancer, and multiple additional indications.
Company Facts
- Founded: 2012
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: Less than $1M
- Total funding: $366.0K
- Last round: Grant (Nov 2020)
- Website: https://www.omnicyte.com
- Phone: 1 (917) 439-7479
Industries & Categories
Biotechnology, Health Care, Product Research
Canonical: https://fsome.com/organization/omnicyte-211399 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.